SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
South32 Limited (SHTLF) trades at a trailing P/E of 67.0, forward P/E of 15.4. Trailing earnings yield is 1.49%, forward earnings yield 6.50%. PEG 0.05 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 67.0).
- Forward P/E 15.4 (down from trailing 67.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.05 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.49% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 6.50% as earnings recover.
Overall SharesGrow Score: 45/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SHTLF
Valuation Multiples
P/E (TTM)67.0
Forward P/E15.4
PEG Ratio0.05
Forward PEG0.05
P/B Ratio0.00
P/S Ratio2.47
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.05
Forward EPS (Est.)$0.20
Book Value / Share$0.00
Revenue / Share$1.28
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.49%
Forward Earnings Yield6.50%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.30 |
$6.12B |
$-1.62B |
-26.4% |
| 2017 |
$0.23 |
$7.2B |
$1.23B |
17.1% |
| 2018 |
$0.25 |
$7.55B |
$1.33B |
17.6% |
| 2019 |
$0.08 |
$7.27B |
$389M |
5.3% |
| 2020 |
$0.03 |
$5.01B |
$-65M |
-1.3% |
| 2021 |
$-0.04 |
$5.48B |
$-195M |
-3.6% |
| 2022 |
$0.57 |
$9.27B |
$2.67B |
28.8% |
| 2023 |
$-0.04 |
$5.65B |
$-173M |
-3.1% |
| 2024 |
$-0.05 |
$5.48B |
$-203M |
-3.7% |
| 2025 |
$0.05 |
$5.78B |
$213M |
3.7% |
